Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Open research · Psilocybin & psilocin

Trial pipeline

Track psilocybin trial phases, recruitment, sponsors and registry completion dates with country filters, source links, comparison and free data exports.

Free access · No subscription for research tools or data exports

Filter the development pipeline

Reset

7 trials match this view; 7 reported facilities; 7 have usable coordinates. Latest indexed registry check Nov 19, 2026 02:23 UTC. Country membership uses reported locations, including locations without coordinates; Mapped-facility counts cover all sites of matching trials, including international sites, and require valid coordinates.

Enrollment sum: 383 across 7 records with a reported count. Planned and actual counts are mixed; this is not a count of unique treated participants.

Recorded study-start years

20211
20241
20251
20263
20271

Current indexed registry status

Recruiting5
Not yet recruiting1
Active, not recruiting1

Reported research conditions

Counts describe indexed registry records, not efficacy or total research activity. A trial can count under several conditions or countries. Unknown dates are excluded from the start-year chart; future years reflect planned starts. Stopped studies may reflect recruitment, funding or strategy and are not automatically treatment failures.

Milestones to investigate

The table is ordered by reported primary completion date. Check whether the registry calls enrollment estimated or actual, when the record was last updated, and whether results have been published. Completion dates are not readout dates; no model-generated success probabilities are assigned.

For late-stage studies, choose PHASE3 above. For studies still underway, choose an exact recruitment status. Use sponsor and country filters to inspect a programme, then save records to compare their designs.

Matching trial records

7 matching registry records. Dates are registry milestones, not promised results announcements.
TrialSponsor and phaseStatusEnrollmentStart / primary completion / completionResearch workflow
Measurement of Serum Cytokine Levels in Samples Collected as Part of a Clinical Trial of Psilocybin for Treatment-resistant Depression.

NCT07164755

Depression - Major Depressive Disorder
King's College London

Phase not reported

Active, not recruiting

Registry updated 2025-09-10

46

ACTUAL

2021-06-21
2026-09
2026-09
Safety, Feasibility, and Tolerability of Psilocybin Treatment for Individuals With Functional Impairment Related to Mood, Anxiety, Trauma and/or Addiction Symptoms: An Open-label Proof-of-concept Study

NCT06442423

Transdiagnostic · Depression - Major Depressive Disorder · Anxiety · PTSD Symptoms · PTSD · Substance Use · Substance Use Disorder (SUD) · OCD
Yale University

PHASE1

Recruiting

Registry updated 2026-11-16

50

ESTIMATED

2024-10-17
2027-12
2027-12
Safety, Tolerability, Outcomes of Psilocybin for Depression (STOP Depression) in Veterans With Spinal Cord Injury

NCT07251491

Spinal Cord Injury · Depression - Major Depressive Disorder · Veteran
James J. Peters Veterans Affairs Medical Center

PHASE1, PHASE2

Recruiting

Registry updated 2026-08-10

30

ESTIMATED

2026-08-06
2028-03-01
2028-03-01
Elucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic Effects: A Randomized, Open-Label, Cross-Over Functional Magnetic Resonance Imaging Trial

NCT07490353

Depression - Major Depressive Disorder · Anhedonia
Medical University of Vienna

PHASE1

Recruiting

Registry updated 2026-03-24

85

ESTIMATED

2025-11-01
2028-05-31
2028-05-31
Group Psilocybin-assisted Cognitive Behavioral Therapy for Major Depressive Disorder

NCT07566104

Depression - Major Depressive Disorder · Psilocybin · Cognitive Behavioral Therapy
University of California, Los Angeles

PHASE2

Not yet recruiting

Registry updated 2026-05-04

30

ESTIMATED

2027-01
2028-12
2028-12
A Pilot Mechanistic RCT of Psilocybin With Mindfulness-based Therapy vs Support for Posttraumatic Stress Disorder (PTSD)

NCT07104916

Post Traumatic Stress Disorder · Depression - Major Depressive Disorder
Anthony P King

PHASE2

Recruiting

Registry updated 2026-10-19

30

ESTIMATED

2026-09-01
2029-09
2029-12
Efficacy of Psilocybin and Trazodone Combination in Treatment-resistant Depression: a Randomized Controlled Proof-of-concept Study (PSILOTRAZ)

NCT07210112

Depression - Major Depressive Disorder · Treatment-resistant Depression (TRD)
Centre Hospitalier St Anne

PHASE2

Recruiting

Registry updated 2026-09-21

112

ESTIMATED

2026-06-30
2029-12-31
2030-06-30

Reported research facilities

Medical University of Vienna, Department of Psychiatry and Psychotherapy, Division of General PsychiatryVienna, State of Vienna, Austria · Coordinates available
GHU Paris Psychiatrie and NeurosciencesParis, France · Coordinates available
King's College London Institute of Psychiatry, Psychology and NeuroscienceLondon, United Kingdom · Coordinates available
Connecticut Mental Health Center - Yale School of MedicineNew Haven, Connecticut, United States · Coordinates available
James J. Peters Department of Veterans Affairs Medical CenterThe Bronx, New York, United States · Coordinates available
The Ohio State University Medical CenterColumbus, Ohio, United States · Coordinates available
UCLA Semel InstituteLos Angeles, California, United States · Coordinates available

This directory includes reported facilities with and without coordinates. For a country-filtered view, locations are labeled as selected-country sites or international sites of matching trials. Facilities are registry-reported trial sites, not an independently verified clinic or research-centre directory. Current services and contact details must be checked at the source.